Vision Disorders Clinical Trial
Official title:
Evaluate Objectively the Change in the Vergence Responses of Binocular and Accommodative Normal Subjects After Performing a Classic Vision Therapy Protocol
A vision therapy protocol for vergence ability is mentioned. The purpose of this study is to evaluate objectively the change in the vergence responses of binocular and accommodative normal subjects after performing a classic vision therapy protocol. This study is an interventional, cross-over, and randomized study.
After the first evaluation, subjects will be classified in the Experimental Group (EG) or Control Group (CG) randomly. There will be 18 subjects in each group. A classic vision therapy protocol for fusional vergence will be performed in the EG and the CG will be doing a placebo therapy, based on studies done before. The EG will do weekly office-based therapy of 45 minutes during 12 weeks and the CG will do weekly office-based placebo therapy of 15 minutes during 12 weeks. This placebo therapy will consist of smooth-pursuit and discrimination exercises that do not influence vergence response. The office-based done by the EG consists of a vergence therapy and its protocol will follow Scheiman's indications protocol. This vision therapy will train both positive and negative fusional vergence amplitudes in the same proportion. A pre-evaluation, a during evaluation, and a post-evaluation will be done at weeks 1, 6, and 12 respectively to all subjects. After the post-evaluation week, the CG will do 12 weeks more of office-based therapy but, this group will do the same conventional vergence protocol as EG. The CG will be evaluated at week 18, and finally, at week 24. During the evaluations, the vergence eye movements will be measured during the positive and negative fusional vergence tests. The break and the recovery points will be evaluated to all the subjects with three different methods performed in a randomized order: (1) objective computer-based test in the haploscopic system, (2) prism bar, and (3) phoropter rotary prisms. All these tests will be performed at 40 cm with a classic central visual target. This study aims to evaluate objectively the change in the vergence responses of binocular and accommodative normal subjects after performing a classic vision therapy protocol. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03872479 -
Single Ascending Dose Study in Participants With LCA10
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02595502 -
Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses
|
N/A | |
Completed |
NCT02485054 -
A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)
|
||
Completed |
NCT00985231 -
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
|
N/A | |
Recruiting |
NCT06077682 -
Cycloplegic Refraction in Pediatric Patients With Esotropia
|
Phase 4 | |
Active, not recruiting |
NCT04123626 -
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
|
Phase 1/Phase 2 | |
Recruiting |
NCT04693247 -
Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction
|
N/A | |
Recruiting |
NCT06451172 -
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
|
Early Phase 1 | |
Completed |
NCT01318577 -
Study of A New Contact Lens Cleaning and Disinfecting Solution
|
N/A | |
Completed |
NCT03763721 -
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation
|
N/A | |
Completed |
NCT05602402 -
To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use
|
N/A | |
Not yet recruiting |
NCT06085430 -
Kubota Glass Parameter Refinement Study
|
N/A | |
Completed |
NCT04347564 -
Usability of the Software MacuFix for the Categorization of Metamorphopsia
|
||
Completed |
NCT01546402 -
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
|
Phase 4 | |
Completed |
NCT01698788 -
Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema
|
N/A | |
Completed |
NCT03169855 -
Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
|
||
Terminated |
NCT03913130 -
Extension Study to Study PQ-110-001 (NCT03140969)
|
Phase 1/Phase 2 | |
Recruiting |
NCT03479021 -
SPOT Vision Screening
|
||
Recruiting |
NCT05600140 -
Viewing Strategy Training in Children With (Cerebral) Visual Impairment
|
N/A | |
Completed |
NCT03780257 -
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
|
Phase 1/Phase 2 |